New breast CT scan could rival MRI for cancer detection
NCT ID NCT05989022
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a low-dose contrast-enhanced breast CT (CE-BCT) can match the accuracy of contrast-enhanced MRI (CE-MRI) for diagnosing breast cancer. 293 women with various breast concerns received both scans, and three independent experts rated the images. The goal was to see if CE-BCT is non-inferior to CE-MRI in detecting lesions. Patient comfort was also measured through questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- contrast agents (Gadovist for MRI, Imeron for breast CT)
- What this could lead to
- If successful, this could offer a faster, more comfortable alternative to MRI for breast cancer diagnosis, potentially reducing scan time and patient anxiety.
- What could go wrong
- This is a completed study comparing imaging methods, not a treatment trial. Even if breast CT matches MRI accuracy, it may not replace MRI for all cases, and radiation exposure from CT is a consideration.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER DIAGNOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DRZ Die Radiologen
Regensburg, Bavaria, 93059, Germany
-
Leiden University Medical Centre
Leiden, 2333 ZA, Netherlands
-
Radiologisches Institut Universitätsklinikum Erlangen
Erlangen, 91054, Germany
-
Stichting Martini Ziekenhuis
Groningen, 9728 NT, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.